e-learning
resources
Virtual 2021
07.09.2021
What's new in respiratory problems in rare and systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary involvement in antisynthetase syndrome: more than myopathy
F. Çiftci (Ankara, Turkey), S. Süslü (Ankara, Turkey), O. Kayacan (Ankara, Turkey)
Source:
Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session:
What's new in respiratory problems in rare and systemic diseases
Session type:
E-poster
Number:
3298
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Çiftci (Ankara, Turkey), S. Süslü (Ankara, Turkey), O. Kayacan (Ankara, Turkey). Pulmonary involvement in antisynthetase syndrome: more than myopathy. 3298
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Pulmonary involvement in antiphospholipid syndrome
Source: Eur Respir Monogr 2019; 86: 124-139
Year: 2019
Pulmonary involvement in Marfan syndrome
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018
Pulmonary involvement in patients with Marfan syndrome
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
Acute respiratory distress syndrome secondary to antisynthetase syndrome is reversible with tacrolimus
Source: Eur Respir J 2008; 31: 213-217
Year: 2008
Cardiac sarcoidosis presenting as a Heerfordt syndrome
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
BOOP as presenting manifestation of idiopathic hyper-eosinophilic syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 375s
Year: 2005
Pulmonary manifestations of hyper-IgE syndromes (HIESs)
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
Source: Eur Respir J 2013; 42: 1271-1282
Year: 2013
Pulmonary manifestations of Sjögren's syndrome
Source: Eur Respir Rev 2016; 25: 110-123
Year: 2016
Down syndrome and pulmonary hemosiderosis: an under-recognized association
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
Non-infectious pulmonary involvement in myelodysplastic syndrome
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Source: Eur Respir J 2008; 32: 244-245
Year: 2008
Nephrotic syndrome associated with pulmonary tuberculosis – case presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 88s
Year: 2007
Pulmonary disorders in patients with polymyositis and dermatomyositis
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001
Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
Pulmonary involvement in primary Sjögren's syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 470s
Year: 2002
Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Pulmonary findings of the patients with Sjogren syndrome
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012
Sarcoidosis presenting as Lofgren‘s syndrome
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept